NEW YORK (GenomeWeb News) – The House of Lords in the UK Parliament will hold an inquiry into the state of genomic medicine, and has put out a public call for experts to give testimony about the progress and the potential impact it will have on clinical medicine.
The House of Lords’ Science and Technology Committee has appointed a sub-committee that will ask a number of big-picture questions about where genomic medicine stands. It is seeking to answer questions such as who is in charge of genomic medical policy, and who reviews such policies, who provides scientific advice on policy, and who monitors and anticipates developments in the field.
The committee also will ask how the regulatory and advisory frameworks function, what gaps there may be in regulations, and how the science is informed by social, ethical, and legal considerations. It also is seeking feedback on how genomic medicine is progressing, what the new developments are, and how fast the science is changing.
Among the other answers it seeks are what groups are involved in coordinating research and development, how effective is the policy and investment framework in supporting the field, what are the current priorities in genomics research, and how does industry figure into those priorities.
The subcommittee also plans to inquire about how the UK’s research efforts compare with other nations in genomics research and about how the genomic information is published, annotated, and presented.
The deadline for submitting written evidence for the inquiry is April 21.
More information about the House of Lords’ call from the genomics community can be found here.